The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from PR Newswire

Medtronic Investors with Significant Losses are Encouraged to Contact Deans & Lyons LLP Securities Lawyers

Thursday, July 18, 2013

Medtronic Investors with Significant Losses are Encouraged to Contact Deans & Lyons LLP Securities Lawyers

09:56 EDT Thursday, July 18, 2013

DALLAS, July 18, 2013 /PRNewswire/ -- Deans & Lyons announced a class action against Medtronic, Inc. (NYSE: MDT).  MDT investors who purchased between December 8, 2010 and August 3, 2011 are encouraged to contact securities attorney Hamilton Lindley at 877-819-8033 or hlindley@deanslyons.com about their rights and remedies by August 26, 2013.

"According the complaint, certain officers and directors at Medtronic issued misleading and/or false information regarding the product Infuse," said securities lawyer Hamilton Lindley. "Prices of MDT stock were artificially inflated as a result of the possible false statements." 

Deans & Lyons has significant experience representing shareholders in securities lawsuits nationwide. stockholders ? or anyone with knowledge about this situation ? should contact lawyer Hamilton Lindley at hlindley@deanslyons.com or 877-819-8033 with questions or concerns.

Hamilton Lindley DEANS & LYONS LLP 325 North Saint Paul Street, Suite 1500 Dallas, TX 75201 Phone: 214-736-7861 Fax: 214-965-8505 Toll-free: 877-819-8033hlindley@deanslyons.comwww.deanslyons.com

SOURCE Deans & Lyons LLP

Products
  • Globe Unlimited

    Digital all access pass across devices. subscribe

  • The Globe and Mail Newspaper

    Newspaper delivered to your doorstep. subscribe

  • Globe2Go

    The digital replica of our newspaper. subscribe

  • Globe eBooks

    A collection of articles by the Globe. subscribe

See all Globe Products

Advertise with us

GlobeLink.ca

Your number one partner for reaching Canada's Influential Achievers. learn more

The Globe at your Workplace
Our Company
Customer Service
Globe Recognition
Mobile Apps
NEWS APP
INVESTING APP
Other Sections